Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Danyi Tablet** is an oral Chinese herbal medicine formula used for chronic nonbacterial prostatitis with the traditional Chinese medicine pattern of blood stasis obstructing with damp-heat descending. The standardized tablet contains extracts prepared from danshen, motherwort, verbena, achyranthes, phellodendron bark, pulsatilla root, and vaccaria seed. Its labeled traditional therapeutic actions are promoting blood circulation to remove stasis and clearing heat and dampness; no single molecular target or validated target-specific mechanism has been established for the complete multi-herb product. The Chinese Pharmacopoeia monograph specifies a film-coated tablet formulation and oral administration. ([db.ouryao.com](https://db.ouryao.com/yaodian/v2025/view?docid=50129&id=1))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Danyi Tablet.